Sheng Ye

Sheng Ye

Auto-generated profile, based on publicly available information

Sheng Ye

National Cerebral and Cardiovascular Center, Suita, Japan

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2026 in Blood Advances
Verified
Journal Article
Open access
KMKeiko Maruyama
Keiko Maruyama
SYSheng Ye
Sheng Ye
YEYuka Eura
Yuka Eura
ATAkihiro Tsuji
Akihiro Tsuji
YFYoshitaka Fujihara
Yoshitaka Fujihara
KKKoichi Kokame
Koichi Kokame
Introns can modulate gene expression through enhancer- or silencer-like elements, as well as intron-mediated enhancement. Protein S (PS), encoded by PROS1, is an anticoagulant cofactor for activated protein C and tissue factor pathway inhibitor. PROS1 spans ~100 kb and harbors an unusually long first intron (~46 kb). We asked whether intron 1 contributes to PS regulation. Reporter assays in HepG2 cells identified discrete intron-1 regions that enhanced or repressed PROS1 promoter activity. CRISPR/Cas9-mediated deletion of most of intron 1 in HepG2 cells reduced endogenous PS mRNA and secreted PS. Mice carrying large intron-1 deletions were viable but showed markedly reduced PS antigen in plasma and platelets versus wild type. Tissue profiling revealed variable decreases in PS mRNA across organs, indicating tissue-dependent regulation. In a patient with congenital PS deficiency who was initially negative by conventional coding-region sequencing, long-read sequencing uncovered rare intron-1 variants that reduced reporter activity. These data show that regulatory sequences within PROS1 intron 1 are necessary to maintain PS expression in vivo and suggest that noncoding intronic variants may contribute to congenital PS deficiency. Our findings support incorporating PROS1 intron 1 and other noncoding PROS1 regions into genetic testing for PS deficiency.